Project cooperation
AI-driven bone marrow-on-chip NAMs predict and prevent therapy resistance in hematologic cancers by analysing mutagenesis pathways.
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Head of Department of molecular oncology at Institute for Medical Research University of Belgrade
Belgrade, Serbia